Premenopausal osteoporosis in a patient with autoimmune polyglandular syndrome: A case report
Open Access
- 7 March 2021
- journal article
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (Supplement), 98-100
- https://doi.org/10.46310/tjim.885771
Abstract
Osteoporosis is a skeletal disease characterized by low bone mass associated with decreased bone strength and increased risk of fractures. Low bone mass in premenopausal women is less common than in postmenopausal women, and bone loss in premenopausal women is usually due to secondary causes such as estrogen deficiency, glucocorticoid exposure, malabsorption, thyroid disorders, and hyperparathyroidism. In women with premenopausal osteoporosis, treatment should be planned according to the underlying secondary causes. In this case report, the importance of investigating the secondary causes leading to premenopausal osteoporosis and its treatment are discussed.Keywords
This publication has 6 references indexed in Scilit:
- Bone mineral accrual from 8 to 30 years of age: An estimation of peak bone massJournal of Bone and Mineral Research, 2011
- The Safety of Bisphosphonate Use in Premenopausal Women on CorticosteroidsCurrent Drug Safety, 2010
- Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic reviewBritish Journal of Sports Medicine, 2006
- The relation between stress fractures and bone mineral density: Evidence from active-duty army womenArchives of Physical Medicine and Rehabilitation, 2000
- Bone Mineral Density Testing and Osteoporosis Education Improve Lifestyle Behaviors in Premenopausal Women: A Prospective StudyJournal of Bone and Mineral Research, 1999
- The diagnosis of osteoporosisJournal of Bone and Mineral Research, 1994